Concepedia

Dennis Lovett

DL

3

Publications

390

Citations

3

H-Index

1991

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dennis Lovett is an author at Memorial Sloan Kettering Cancer Center specializing in immunology, immunotherapy, and medicine.

Top concepts

MedicineOncologyImmunologyImmunotherapyHealthRadiologyHematologyPharmacologyTumor BiologyCancer Therapy

Publications per year

1991–2012

3

Publications

3

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

David A. Scheinberg, Dennis Lovett, Chaitanya Divgi et al. · Journal of Clinical Oncology · 1991 · 227 citations

Mixed-phenotype Acute Leukemia, Immunology, Immunotherapy +20

Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.

Michael Schwartz, Dennis Lovett, Arlene Redner et al. · Journal of Clinical Oncology · 1993 · 130 citations

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates

Diego A. Gianolio, Cécile Rouleau, William E. Bauta et al. · Cancer Chemotherapy and Pharmacology · 2012 · 33 citations

Tumor Biology, Novel Antibody–drug Conjugates, Drug Targeting +12

Rows per page

1–3 of 3